Global Trends and Emerging Directions in Acute Respiratory Distress Syndrome (ARDS) Research: A Comprehensive Bibliometric Analysis (2020–2025)
Bibliometric Analysis of ARDS (2020-2025)
Keywords:
ARDS, Bibliometric analysis, COVID-19Abstract
Background: Acute respiratory distress syndrome (ARDS) is a critical condition associated with high morbidity and mortality. The COVID-19 pandemic has dramatically reshaped ARDS research output and priorities.
Objective: To perform a bibliometric analysis of global ARDS research from 2020 to 2025, identifying publication trends, influential contributors, and emerging research themes.
Methods: A bibliometric analysis was conducted using publications indexed in major databases (e.g., Web of Science Core Collection and Scopus). Data were analyzed using bibliometric tools, such as VOSviewer and CiteSpace. Indicators included publication output, citations, authorship, institutional productivity, and keyword co-occurrence.
Results: ARDS-related publications peaked between 2020 and 2021, largely driven by COVID-19-related research. The United States led in productivity and citations, followed by China, Italy, and the United Kingdom. The core journals included Critical Care Medicine and Intensive Care Medicine. The major research clusters included COVID-19-associated ARDS, mechanical ventilation strategies, ECMO, and inflammatory biomarkers. Emerging topics after 2022 included precision medicine, long-term outcomes, and novel therapeutics.
Conclusion: ARDS research experienced rapid expansion during the COVID-19 era, followed by a shift toward mechanistic understanding and personalized treatment approaches. Future studies should focus on phenotyping and targeted therapies.
References
1. Thompson BT, Chambers RC, and Liu KD. Acute respiratory distress syndrome (ARDS). N Engl J Med. 2017;377(6):562–572.
2. Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–2533.
3. Grasselli G, Tonetti T, Protti A, et al. Pathophysiology of COVID-19-associated ARDS. Lancet Respir Med. 2020;8(12):1201–1208.
4. Donthu N, Kumar S, Mukherjee D, et al. How to conduct a bibliometric analysis. J Bus Res. 2021;133:285–296.
5. Else H. How a torrent of COVID science changed research publishing. Nature. 2020;588:553.
6. Fan E, Beitler JR, Brochard L, et al. COVID-19-associated ARDS: clinical perspectives. Am J Respir Crit Care Med. 2020;201(11):1317–1328.
7. Matthay MA, Zemans RL, Zimmerman GA, et al. Acute respiratory distress syndrome. Nat Rev Dis Primers. 2019;5(1):18.
8. Calfee CS, Delucchi K, Parsons PE, et al. Subphenotypes in ARDS: latent class analysis. Lancet Respir Med. 2014;2(8):611–620.
9. Sinha P, Calfee CS. Phenotypes in ARDS: moving toward precision medicine. Curr Opin Crit Care. 2019;25(1):12–20.
10. Herridge MS, Moss M, Hough CL, et al. Recovery and outcomes after ARDS. N Engl J Med. 2011;364(14):1293–1304.
11. Rezoagli E, Fumagalli R, Bellani G. Definition and epidemiology of ARDS. Respir Care. 2017;62(12):1577–1586.
12. Gattinoni L, Marini JJ, Camporota L. The evolving definition of ARDS. Intensive Care Med. 2023;49(3):321–324.
13. Global ARDS Definition Task Force. Updated ARDS definition 2024. Intensive Care Med. 2024;50:1–10.
14. Bos LD, Ware LB. Acute respiratory distress syndrome: causes and phenotypes. Lancet. 2022;399(10329):1145–1156.
15. Famous KR, Delucchi K, Ware LB, et al. ARDS subphenotypes and treatment response. Am J Respir Crit Care Med. 2017;195(3):331–338.
16. Seymour CW, Kennedy JN, Wang S, et al. Derivation of ARDS phenotypes. JAMA. 2019;321(20):2003–2017.
17. Matthay MA, Calfee CS, Zhuo H, et al. Treatment of ARDS with stem cells. Chest. 2019;155(3):565–575.
18. Bos LDJ, Schouten LR, van Vught LA, et al. Identification of biomarkers in ARDS. Lancet Respir Med. 2017;5(4):303–312.
19. Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of ARDS. N Engl J Med. 2005;353(16):1685–1693.
20. Bellani G, Laffey JG, Pham T, et al. Epidemiology of ARDS worldwide. JAMA. 2016;315(8):788–800.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Mert Aydemir
This work is licensed under a Creative Commons Attribution 4.0 International License.
